Status:
UNKNOWN
The Role of a Clinical Pharmacist in Lifestyle Modification in Type 2 Diabetic Patients With Peripheral Neuropathy
Lead Sponsor:
Hawler Medical University
Conditions:
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The aims of this study are to determine the prevalence of diabetic peripheral neuropathy among the diabetic patients, to determine the association between the clinical profiles of the diabetic patient...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Aged 18 years or older.
- Both sex.
- Diagnosed with type 2 diabetes at least one year previously.
- Took at least one prescribed medication for diabetes.
- Diagnosed as diabetic peripheral neuropathy based on clinical
- Exclusion Criteria:
- History of alcohol consumption.
- Thyroid gland disorder.
- Any kidney disorder.
- Any conditions that could confound assessment of pain due to diabetic peripheral neuropathy.
- Have foot injury or open sore.
- Pregnant females or who plan to become pregnant during the study period.
- Any serious medical condition that might prevent completion or hinder compliance with exercise.
- \-
Exclusion
Key Trial Info
Start Date :
December 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 23 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03356041
Start Date
December 20 2017
End Date
March 23 2018
Last Update
November 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prof. Kawa Dizaye
Erbil, Iraq